首页> 外文期刊>Chinese Jouranl of Integrative Medicine >Advance in Basic and Clinical Research of Xuezhikang Capsule
【24h】

Advance in Basic and Clinical Research of Xuezhikang Capsule

机译:血脂康胶囊的基础和临床研究进展

获取原文
获取原文并翻译 | 示例
       

摘要

Chinese coronary secondary prevention study (CCSPS) is a key project in the field of medicine of the Ninth Five-year Plan of China, and is also called the Study of Xuezhikang Capsule ( XZK) in regulating blood lipids for secondary prevention of coronary heart diseases. Since the results of the study was publicized in June 2004 at the news release and deliberation by experts took place in the Great Hall of the People in Beijing, wide attention and high opinions have been gotten, and at the same time, thinking at the deeper layer raised in the medical circle. A simple commentary on the study is made and given in this paper for readers' reference in their further exploration.
机译:中国冠状动脉二级预防研究(CCSPS)是中国“九五”医学领域的重点项目,又被称为血脂康胶囊(XZK)调节血脂的研究,用于冠心病的二级预防。自从2004年6月该研究结果在新闻发布会上公布以来,专家们在北京人民大会堂进行了审议,引起了广泛的关注和高度评价,同时,人们在更深入地思考。在医学界提出的层。对该研究进行了简单的评述,并在本文中给出,以供读者进一步探索时参考。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号